Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 1
LINC01356 is a long intergenic noncoding RNA annotated in the human genome that lacks a significant protein coding open reading frame and is presumed to function through RNA mediated mechanisms. Like many lincRNAs, it is expected to act in cis or trans by scaffolding RNA binding proteins, modulating chromatin states, influencing transcription, or participating in posttranscriptional regulation such as microRNA interaction and mRNA stability control. Public expression datasets indicate tissue and context specific transcription with enrichment in certain cancers and immune related conditions, but definitive roles remain incompletely defined. Genomic localization and conserved synteny suggest regulatory potential near neighboring genes, and differential expression has been reported in tumor versus normal comparisons, which may correlate with proliferation, invasion, or therapy response. Experimental characterization typically employs RNA sequencing, quantitative PCR, knockdown or CRISPR interference to perturb expression, RNA immunoprecipitation to identify binding partners, and chromatin assays to assess epigenetic effects. Overall, LINC01356 represents a candidate regulatory noncoding RNA with emerging but still limited functional evidence, and further studies are needed to clarify its mechanisms and disease relevance.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
蛋白别名: Long intergenic non-protein coding RNA 1356